RapamycinFungusV1, Main, Exploration, bibRecord, 001824

Replicating oncolytic virus therapeutics - Third International Meeting.

Identifieur interne : 001824 ( Main/Exploration ); précédent : 001823; suivant : 001825

Replicating oncolytic virus therapeutics - Third International Meeting.

Auteurs : John Bell [Canada]

Source :

IDrugs : the investigational drugs journal [ 1369-7056 ] ; 2005.

RBID : pubmed:15883909

Descripteurs français

KwdFr :
- Adenoviridae (physiologie), Animaux (MeSH), Essais cliniques comme sujet (MeSH), Humains (MeSH), Immunosuppresseurs (usage thérapeutique), Réplication virale (physiologie), Sirolimus (analogues et dérivés), Sirolimus (usage thérapeutique), Tests de criblage d'agents antitumoraux (méthodes), Tumeurs du côlon (anatomopathologie), Tumeurs du côlon (thérapie), Tumeurs du côlon (virologie), Vaccins antiviraux (administration et posologie), Vaccins antiviraux (usage thérapeutique), Virus de la maladie de Newcastle (immunologie), Virus de la maladie de Newcastle (physiologie), Évérolimus (MeSH).
MESH :
- administration et posologie : Vaccins antiviraux.
- analogues et dérivés : Sirolimus.
- anatomopathologie : Tumeurs du côlon.
- immunologie : Virus de la maladie de Newcastle.
- méthodes : Tests de criblage d'agents antitumoraux.
- physiologie : Adenoviridae, Réplication virale, Virus de la maladie de Newcastle.
- thérapie : Tumeurs du côlon.
- usage thérapeutique : Immunosuppresseurs, Sirolimus, Vaccins antiviraux.
- virologie : Tumeurs du côlon.
- Animaux, Essais cliniques comme sujet, Humains, Évérolimus.

English descriptors

KwdEn :
- Adenoviridae (physiology), Animals (MeSH), Clinical Trials as Topic (MeSH), Colonic Neoplasms (pathology), Colonic Neoplasms (therapy), Colonic Neoplasms (virology), Drug Screening Assays, Antitumor (methods), Everolimus (MeSH), Humans (MeSH), Immunosuppressive Agents (therapeutic use), Newcastle disease virus (immunology), Newcastle disease virus (physiology), Sirolimus (analogs & derivatives), Sirolimus (therapeutic use), Viral Vaccines (administration & dosage), Viral Vaccines (therapeutic use), Virus Replication (physiology).
MESH :
- chemical , administration & dosage : Viral Vaccines.
- chemical , analogs & derivatives : Sirolimus.
- chemical , therapeutic use : Immunosuppressive Agents, Sirolimus, Viral Vaccines.
- chemical : Everolimus.
- immunology : Newcastle disease virus.
- methods : Drug Screening Assays, Antitumor.
- pathology : Colonic Neoplasms.
- physiology : Adenoviridae, Newcastle disease virus, Virus Replication.
- therapy : Colonic Neoplasms.
- virology : Colonic Neoplasms.
- Animals, Clinical Trials as Topic, Humans.

PubMed: 15883909

Affiliations:

Canada

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001839
to stream Main, to step Curation: 001839

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Replicating oncolytic virus therapeutics - Third International Meeting.</title>
<author><name sortKey="Bell, John" sort="Bell, John" uniqKey="Bell J" first="John" last="Bell">John Bell</name>
<affiliation wicri:level="1"><nlm:affiliation>Ottawa Regional Cancer Centre, Ontario, Canada. jbell@ohri.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ottawa Regional Cancer Centre, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15883909</idno>
<idno type="pmid">15883909</idno>
<idno type="wicri:Area/Main/Corpus">001839</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001839</idno>
<idno type="wicri:Area/Main/Curation">001839</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001839</idno>
<idno type="wicri:Area/Main/Exploration">001839</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Replicating oncolytic virus therapeutics - Third International Meeting.</title>
<author><name sortKey="Bell, John" sort="Bell, John" uniqKey="Bell J" first="John" last="Bell">John Bell</name>
<affiliation wicri:level="1"><nlm:affiliation>Ottawa Regional Cancer Centre, Ontario, Canada. jbell@ohri.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ottawa Regional Cancer Centre, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">IDrugs : the investigational drugs journal</title>
<idno type="ISSN">1369-7056</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenoviridae (physiology)</term>
<term>Animals (MeSH)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Colonic Neoplasms (pathology)</term>
<term>Colonic Neoplasms (therapy)</term>
<term>Colonic Neoplasms (virology)</term>
<term>Drug Screening Assays, Antitumor (methods)</term>
<term>Everolimus (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Newcastle disease virus (immunology)</term>
<term>Newcastle disease virus (physiology)</term>
<term>Sirolimus (analogs & derivatives)</term>
<term>Sirolimus (therapeutic use)</term>
<term>Viral Vaccines (administration & dosage)</term>
<term>Viral Vaccines (therapeutic use)</term>
<term>Virus Replication (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adenoviridae (physiologie)</term>
<term>Animaux (MeSH)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Réplication virale (physiologie)</term>
<term>Sirolimus (analogues et dérivés)</term>
<term>Sirolimus (usage thérapeutique)</term>
<term>Tests de criblage d'agents antitumoraux (méthodes)</term>
<term>Tumeurs du côlon (anatomopathologie)</term>
<term>Tumeurs du côlon (thérapie)</term>
<term>Tumeurs du côlon (virologie)</term>
<term>Vaccins antiviraux (administration et posologie)</term>
<term>Vaccins antiviraux (usage thérapeutique)</term>
<term>Virus de la maladie de Newcastle (immunologie)</term>
<term>Virus de la maladie de Newcastle (physiologie)</term>
<term>Évérolimus (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Immunosuppressive Agents</term>
<term>Sirolimus</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Everolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du côlon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Virus de la maladie de Newcastle</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Newcastle disease virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Screening Assays, Antitumor</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Tests de criblage d'agents antitumoraux</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Colonic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Adenoviridae</term>
<term>Réplication virale</term>
<term>Virus de la maladie de Newcastle</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Adenoviridae</term>
<term>Newcastle disease virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Colonic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs du côlon</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Immunosuppresseurs</term>
<term>Sirolimus</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Tumeurs du côlon</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Colonic Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Clinical Trials as Topic</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Évérolimus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15883909</PMID>
<DateCompleted><Year>2006</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1369-7056</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>5</Issue>
<PubDate><Year>2005</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>IDrugs : the investigational drugs journal</Title>
<ISOAbbreviation>IDrugs</ISOAbbreviation>
</Journal>
<ArticleTitle>Replicating oncolytic virus therapeutics - Third International Meeting.</ArticleTitle>
<Pagination><MedlinePgn>360-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bell</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Ottawa Regional Cancer Centre, Ontario, Canada. jbell@ohri.ca</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>IDrugs</MedlineTA>
<NlmUniqueID>100883655</NlmUniqueID>
<ISSNLinking>1369-7056</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C424862">Newcastle disease virus vaccine MTH-68-H</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9HW64Q8G6G</RegistryNumber>
<NameOfSubstance UI="D000068338">Everolimus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068338" MajorTopicYN="N">Everolimus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009522" MajorTopicYN="N">Newcastle disease virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>5</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>5</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15883909</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Bell, John" sort="Bell, John" uniqKey="Bell J" first="John" last="Bell">John Bell</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001824 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001824 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:15883909
   |texte=   Replicating oncolytic virus therapeutics - Third International Meeting.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:15883909" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020

	Serveur d'exploration sur la rapamycine et les champignons
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la rapamycine et les champignons

Replicating oncolytic virus therapeutics - Third International Meeting.

Replicating oncolytic virus therapeutics - Third International Meeting.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki